John Kollins

Prior to cofounding Satsuma Pharmaceuticals in 2016, John was founder and Managing Director of Parnassus Advisors, LLC, where he provided strategy and business / corporate development services to biopharmaceutical companies.  Since entering the biopharmaceutical industry in 1989, John has served in C-level and senior executive roles in multiple public and private biopharmaceutical companies, including Transcept Pharmaceuticals, OXiGENE, CovX, Renovis, Athena Neurosciences / Elan Pharmaceuticals, and Immunex.  John earned an MBA from the University of Virginia’s Darden School and an engineering degree from Duke University.